| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely mebeverine hydrochloride 200 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely theophylline 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely theophylline 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely nifedipine 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely nifedipine 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely isosorbide mononitrate 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely isosorbide mononitrate 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Ibuprofen 300 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Ibuprofen 300 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely isosorbide dinitrate 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely isosorbide dinitrate 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Tramadol hydrochloride 200 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Tramadol hydrochloride 200 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Nicardipine hydrochloride 45 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Nicardipine hydrochloride 45 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Theophylline 125 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Theophylline 125 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely theophylline 250 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely theophylline 250 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Methylphenidate hydrochloride 40 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Methylphenidate hydrochloride 40 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely morphine sulfate 120 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely morphine sulfate 120 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
| Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Nifedipine 20 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Nifedipine 20 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely flurbiprofen 200 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely flurbiprofen 200 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Venlafaxine (as venlafaxine hydrochloride) 150 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Venlafaxine (as venlafaxine hydrochloride) 150 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 2 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 2 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Valproic acid 150 mg gastro-resistant oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Valproic acid 150 mg gastro-resistant oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Trifluoperazine (as trifluoperazine hydrochloride) 10 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Trifluoperazine (as trifluoperazine hydrochloride) 10 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Trifluoperazine (as trifluoperazine hydrochloride) 15 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Trifluoperazine (as trifluoperazine hydrochloride) 15 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely trospium chloride 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely trospium chloride 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Verapamil hydrochloride 180 mg prolonged-release oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Verapamil hydrochloride 180 mg prolonged-release oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely venlafaxine (as venlafaxine hydrochloride) 75 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely venlafaxine (as venlafaxine hydrochloride) 75 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely verapamil hydrochloride 240 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely verapamil hydrochloride 240 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely trandolapril 2 milligram and verapamil hydrochloride 180 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely trandolapril 2 milligram and verapamil hydrochloride 180 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
| Product containing precisely trandolapril 2 milligram and verapamil hydrochloride 180 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely amantadine hydrochloride 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely azapropazone 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely cevimeline 30 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely amprenavir 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Amobarbital sodium 50 mg and secobarbital sodium 50 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| disopyramid 100 mg, kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely acemetacin 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| amlodipinbesilat 5 milligram och benazeprilhydroklorid 20 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Celecoxib 200 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely amprenavir 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely ceritinib 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely digoxin 100 microgram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| disopyramid 150 mg, kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely celecoxib 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely chlorphenamine maleate 8 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Alverine citrate 60 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| acebutolol 200 mg, kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely doxercalciferol 500 nanogram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Balsalazide disodium 750 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Cefradine 500 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely fenofibrate 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| amlodipinbesilat 10 milligram och benazeprilhydroklorid 20 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely acrivastine 8 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely danazol 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| cefalexinmonohydrat 750 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| anagrelidhydroklorid 500 mikrogram, kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely celecoxib 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Cinoxacin 250 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| anagrelidhydroklorid 1 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Ciclosporin 50 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely diltiazem hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| azitromycin (som azitromycindihydrat) 250 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Benzonatate 200 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely alpha tocopherol acetate 400 international unit/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| ampicillintrihydrat 500 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
| doxepinhydroklorid 150 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|